Dys-regulated Gene Expression Networks by Meta-Analysis of Microarray Data on Oral Squamous Cell Carcinoma

[1]  J. Foulley,et al.  Moderated effect size and P-value combinations for microarray meta-analyses , 2009, Bioinform..

[2]  R. Pathmanathan,et al.  Gene expression in human oral squamous cell carcinoma is influenced by risk factor exposure. , 2009, Oral oncology.

[3]  X. Cui,et al.  Consistency Analysis of Redundant Probe Sets on Affymetrix Three-Prime Expression Arrays and Applications to Differential mRNA Processing , 2009, PloS one.

[4]  Simon Talbot,et al.  Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis , 2009, BMC Cancer.

[5]  E. Tajara,et al.  Global gene expression profiling of oral cavity cancers suggests molecular heterogeneity within anatomic subsites , 2008, BMC Research Notes.

[6]  Ralf Krahe,et al.  Molecular signatures of metastasis in head and neck cancer , 2008, Head & neck.

[7]  H. Kuo,et al.  The Evolving Transcriptome of Head and Neck Squamous Cell Carcinoma: A Systematic Review , 2008, PloS one.

[8]  Hua Li,et al.  A statistical framework for consolidating "sibling" probe sets for Affymetrix GeneChip data , 2008, BMC Genomics.

[9]  Hui Ye,et al.  Transcriptomic dissection of tongue squamous cell carcinoma , 2008, BMC Genomics.

[10]  Hui Yu,et al.  Transcript-level annotation of Affymetrix probesets improves the interpretation of gene expression data , 2007, BMC Bioinformatics.

[11]  Y. Wong,et al.  Increase of disintergin metalloprotease 10 (ADAM10) expression in oral squamous cell carcinoma. , 2007, Cancer letters.

[12]  E. Baker,et al.  The matrix metalloproteinase system in oral squamous cell carcinoma. , 2006, The British journal of oral & maxillofacial surgery.

[13]  V. Kosma,et al.  High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma , 2006, Journal of Clinical Pathology.

[14]  J. Mesirov,et al.  From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005 .

[15]  A. Hara,et al.  Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity , 2005, Journal of Cancer Research and Clinical Oncology.

[16]  Hung-Ming Wang,et al.  Identification of differentially expressed genes in oral squamous cell carcinoma (OSCC): Overexpression of NPM, CDK1 and NDRG1 and underexpression of CHES1 , 2005, International journal of cancer.

[17]  N. Seki,et al.  Aberrant expression of RAB1A in human tongue cancer , 2005, British Journal of Cancer.

[18]  T. Salo,et al.  Matrix metalloproteinases (MMPs) in oral diseases. , 2004, Oral diseases.

[19]  D. Koller,et al.  A module map showing conditional activity of expression modules in cancer , 2004, Nature Genetics.

[20]  C. Chi,et al.  Increased expression of amyloid precursor protein in oral squamous cell carcinoma , 2004, International journal of cancer.

[21]  E. Otero-Rey,et al.  DNA microarrays in oral cancer. , 2004, Medicina oral : organo oficial de la Sociedad Espanola de Medicina Oral y de la Academia Iberoamericana de Patologia y Medicina Bucal.

[22]  A. Evsikov,et al.  Comment on " 'Stemness': Transcriptional Profiling of Embryonic and Adult Stem Cells" and "A Stem Cell Molecular Signature" (II) , 2003, Science.

[23]  B. De Moor,et al.  Comparison and meta-analysis of microarray data: from the bench to the computer desk. , 2003, Trends in genetics : TIG.

[24]  Charles Zegar,et al.  Advantages and limitations of microarray technology in human cancer , 2003, Oncogene.

[25]  Ivan Stamenkovic,et al.  Extracellular matrix remodelling: the role of matrix metalloproteinases , 2003, The Journal of pathology.

[26]  B. Das,et al.  Oral cancer: reviewing the present understanding of its molecular mechanism and exploring the future directions for its effective management. , 2003, Oral oncology.

[27]  S. Devesa,et al.  Oral cavity and pharynx cancer incidence rates in the United States, 1975-1998. , 2002, Oral oncology.

[28]  J. Engler,et al.  Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells. , 2001, Cancer research.

[29]  H. Tanzawa,et al.  Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control. , 2000, Oral oncology.

[30]  Seong-Doo Hong,et al.  Expression of matrix metalloproteinase-2 and -9 in oral squamous cell carcinomas with regard to the metastatic potential. , 2000, Oral oncology.

[31]  H. Takeuchi,et al.  Expression of MMPS, MT‐MMP, and TIMPs in squamous cell carcinoma of the oral cavity: Correlations with tumor invasion and metastasis , 1999, Head & neck.

[32]  P. Speight,et al.  Matrix metalloproteinases and oral cancer. , 1999, Oral oncology.

[33]  J. Guillem,et al.  Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis. , 1999, Carcinogenesis.

[34]  H. Larjava,et al.  Matrix Metalloproteinases (MMP-2 and MMP-9) of the Oral Cavity: Cellular Origin and Relationship to Periodontal Status , 1994, Journal of dental research.

[35]  Masashi Sugiyama,et al.  Integrin expression in normal, hyperplastic, dysplastic, and malignant oral epithelium , 1993, The Journal of pathology.

[36]  E. Suchman,et al.  The American Soldier: Adjustment During Army Life. , 1949 .

[37]  H. B. Mann,et al.  On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other , 1947 .

[38]  W. Wąsowicz,et al.  Reference genes for gene expression studies on non-small cell lung cancer. , 2009, Acta biochimica Polonica.

[39]  J. Reibel.  Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. , 2003, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[40]  J Belcher,et al.  Nonparametric methods. , 2001, Nurse researcher.

[41]  P. Marchisio,et al.  Integrin expression in head and neck cancers. , 1995, Acta oto-laryngologica.

[42]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[43]  J. Hemelrijk,et al.  Some remarks on the combination of independent tests , 1953 .